Planet Labs PBC

The stock is still in a corrective regime after a powerful run, trading below its 200-day average and well under the 52-week high. The longer-term setup remains volatile, with a beta above 2, so shareholders should expect sharp swings even when the broader trend stabilizes.

Street sentiment stays constructive: consensus is Buy, with 13 Buy and 9 Hold ratings and no Sell calls. The target stack has moved higher in recent months, with a $43.83 consensus and a $49.5 median, though the latest move was a modest trim to $25 from Goldman Sachs.

Expectations still point to losses, but the revenue line is growing fast enough to keep the story intact. Analysts see 2027 revenue at $436.1 million and 2028 at $569.9 million, while EPS is forecast to improve from -$0.099 to -$0.022; shareholders should watch whether margin progress keeps pace.

Recent insider activity leans negative on discretionary trading, led by sizable July sales from the CEO and co-founder/strategy chief. The award entries look like routine equity grants, but the open-market selling from senior leadership is the clearest signal and outweighs the noise.

Profitability is still weak, but the cash profile is improving. Gross margin is 55.6% and revenue grew 42.1% year over year, while operating cash flow was $134.4 million and free cash flow reached $211.1 million for fiscal 2026.

Planet Labs competes on recurring geospatial data and high-cadence imagery, which supports a differentiated platform versus traditional aerospace names. The valuation still reflects growth optionality rather than current earnings power, with the market paying up for future scale.